Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

D Walters

Showing results (571-580 of 620) with videos related to

Pageof 62
Sort By:
Canadian Journal of Gastroenterology & Hepatology|June 16, 2015
Toward enteral nutrition for the treatment of pediatric Crohn disease in Canada: a workshop to identify barriers and enablersJohan Van Limbergen, Jennifer Haskett, Anne M Griffiths, et al.
Canadian Journal of Gastroenterology & Hepatology|June 9, 2017
Allied Health Professional Support in Pediatric Inflammatory Bowel Disease: A Survey from the Canadian Children Inflammatory Bowel Disease Network-A Joint Partnership of CIHR and the CH.I.L.D. FoundationWael El-Matary, Eric I Benchimol, David Mack, et al.
Scientific Reports|March 16, 2021
Novel CARMIL2 loss-of-function variants are associated with pediatric inflammatory bowel diseaseLuca Bosa, Vritika Batura, Davide Colavito, et al.
Inflammatory Bowel Diseases|February 11, 2026
Primary infliximab failure in pediatric colonic inflammatory bowel disease: Development of a proteomics predictive model using a prospective Canadian cohortAmanda Ricciuto, Andrei L Turinsky, Anne M Griffiths, et al.
Inflammatory Bowel Diseases|May 3, 2012
IL-10R polymorphisms are associated with very-early-onset ulcerative colitisChristopher J Moran, Thomas D Walters, Cong-Hui Guo, et al.
The American Journal of Gastroenterology|October 3, 2023
Adalimumab vs Infliximab in Luminal Pediatric Crohn's Disease: Comparable Outcomes in a Prospective Multicenter Cohort StudyJennifer C deBruyn, Hien Q Huynh, Anne M Griffiths, et al.
Alimentary Pharmacology & Therapeutics|July 16, 2013
Review article: a clinician's guide for therapeutic drug monitoring of infliximab in inflammatory bowel diseaseR Khanna, B D Sattin, W Afif, et al.
JCI Insight|September 21, 2018
Microbiota-sensitive epigenetic signature predicts inflammation in Crohn's diseaseDaniel Kelly, Michael Kotliar, Vivienne Woo, et al.
The Journal of Pediatrics|May 30, 2024
Mental Health Experiences of Adolescents and Young Adults with Inflammatory Bowel Disease During Transition to Adult Care: A Qualitative Descriptive StudyBrooke Allemang, Mira Browne, Melanie Barwick, et al.
Clinical Gastroenterology and Hepatology : the Official Clinical Practice Journal of the American Gastroenterological Association|August 28, 2022
Multicenter Cohort Study of Infliximab Pharmacokinetics and Therapy Response in Pediatric Acute Severe Ulcerative ColitisKaitlin G Whaley, Ye Xiong, Rebekah Karns, et al.
Pageof 62

Showing results (571-580 of 620) with videos related to

Sort By:
Pageof 62
Canadian Journal of Gastroenterology & Hepatology|June 16, 2015
Toward enteral nutrition for the treatment of pediatric Crohn disease in Canada: a workshop to identify barriers and enablersJohan Van Limbergen, Jennifer Haskett, Anne M Griffiths, et al.
Canadian Journal of Gastroenterology & Hepatology|June 9, 2017
Allied Health Professional Support in Pediatric Inflammatory Bowel Disease: A Survey from the Canadian Children Inflammatory Bowel Disease Network-A Joint Partnership of CIHR and the CH.I.L.D. FoundationWael El-Matary, Eric I Benchimol, David Mack, et al.
Scientific Reports|March 16, 2021
Novel CARMIL2 loss-of-function variants are associated with pediatric inflammatory bowel diseaseLuca Bosa, Vritika Batura, Davide Colavito, et al.
Inflammatory Bowel Diseases|February 11, 2026
Primary infliximab failure in pediatric colonic inflammatory bowel disease: Development of a proteomics predictive model using a prospective Canadian cohortAmanda Ricciuto, Andrei L Turinsky, Anne M Griffiths, et al.
Inflammatory Bowel Diseases|May 3, 2012
IL-10R polymorphisms are associated with very-early-onset ulcerative colitisChristopher J Moran, Thomas D Walters, Cong-Hui Guo, et al.
The American Journal of Gastroenterology|October 3, 2023
Adalimumab vs Infliximab in Luminal Pediatric Crohn's Disease: Comparable Outcomes in a Prospective Multicenter Cohort StudyJennifer C deBruyn, Hien Q Huynh, Anne M Griffiths, et al.
Alimentary Pharmacology & Therapeutics|July 16, 2013
Review article: a clinician's guide for therapeutic drug monitoring of infliximab in inflammatory bowel diseaseR Khanna, B D Sattin, W Afif, et al.
JCI Insight|September 21, 2018
Microbiota-sensitive epigenetic signature predicts inflammation in Crohn's diseaseDaniel Kelly, Michael Kotliar, Vivienne Woo, et al.
The Journal of Pediatrics|May 30, 2024
Mental Health Experiences of Adolescents and Young Adults with Inflammatory Bowel Disease During Transition to Adult Care: A Qualitative Descriptive StudyBrooke Allemang, Mira Browne, Melanie Barwick, et al.
Clinical Gastroenterology and Hepatology : the Official Clinical Practice Journal of the American Gastroenterological Association|August 28, 2022
Multicenter Cohort Study of Infliximab Pharmacokinetics and Therapy Response in Pediatric Acute Severe Ulcerative ColitisKaitlin G Whaley, Ye Xiong, Rebekah Karns, et al.
Pageof 62